Trump administration prepares new dietary guidelines for January rollout, launching major food policy overhaul in 2026 to ...
The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...
The report focuses on PFAS intentionally added to cosmetic products as ingredients, rather than PFAS that may be present as ...
The FDA gave its decision despite acknowledging Corcept's trial having met its primary endpoint and that data from another trial provided confirmatory evidence. Chief Executive Joseph Belanoff said ...
The FDA says the facility was operating under insanitary conditions after finding the presence of rodents, rodent urine and ...
Outlook Therapeutics said on Wednesday the U.S. health regulator has declined to approve its drug for a type of eye disease, ...
The U.S. Food and Drug Administration determined that the facility was operating under insanitary conditions, including the ...
Outlook Therapeutics received notice that the Food and Drug Administration can't approve its biologics license application for a drug designed to treat macular degeneration.
Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...
Kratom and 7-OH products are available in many smoke shops. But earlier this year, the FDA recommended certain 7-OH products ...
The Food and Drug Administration announced on Dec. 24 that Consumers Supply Distributing, LLC, based out of Iowa, is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results